Specialist Internal Medicine Practice

At the Specialist Internal Medicine Practice, investigators are exploring new therapeutic strategies for ulcerative colitis, a major condition within digestive system diseases. The focus is on assessing whether a targeted biologic can achieve superior disease control compared with conventional therapy.

• Evaluation of top‑down treatment approach
• Comparison of biologic versus standard immunosuppression
• Assessment of long‑term remission outcomes

Findings aim to expand options for patients newly diagnosed with moderate‑to‑severe disease and could influence future care standards.

Researchers at the Hamburg site are conducting studies on Crohn’s disease, another key focus of digestive system diseases. The trials test a novel biologic agent against traditional treatment to determine its ability to induce deep remission.

• Investigation of induction and maintenance therapy
• Measurement of deep remission rates
• Analysis of treatment durability over a year

Successful results could provide a new standard for managing moderate‑to‑severe Crohn’s disease.